0001493152-24-024753.txt : 20240621 0001493152-24-024753.hdr.sgml : 20240621 20240621163027 ACCESSION NUMBER: 0001493152-24-024753 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240618 FILED AS OF DATE: 20240621 DATE AS OF CHANGE: 20240621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shekhat Denil Nanji CENTRAL INDEX KEY: 0002016605 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41765 FILM NUMBER: 241060897 MAIL ADDRESS: STREET 1: MIRA PHARMACEUTICALS, INC. STREET 2: 1200 BRICKELL AVENUE, SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MIRA PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001904286 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 853354547 STATE OF INCORPORATION: FL BUSINESS ADDRESS: STREET 1: 1200 BRICKELL AVENUE STREET 2: SUITE 1950 #1183 CITY: MIAMI STATE: FL ZIP: 33131 BUSINESS PHONE: 813-369-5150 MAIL ADDRESS: STREET 1: 324 SOUTH HYDE PARK AVENUE, SUITE 350 CITY: TAMPA STATE: FL ZIP: 33606 FORMER COMPANY: FORMER CONFORMED NAME: Mira1a Therapeutics, Inc. DATE OF NAME CHANGE: 20220112 4 1 ownership.xml X0508 4 2024-06-18 0 0001904286 MIRA PHARMACEUTICALS, INC. MIRA 0002016605 Shekhat Denil Nanji C/O MIRA PHARMACEUTICALS, INC. 1200 BRICKELL AVE. SUITE 1950 #1183 MIAMI FL 33131 1 0 0 0 0 Nonqualified Stock Option (right to buy) 0.71 2024-06-18 4 A 0 50000 0 A 2034-06-18 Common Stock 50000 41666 D The exercise price of the stock options issued to the Reporting Person is equal to the Nasdaq Official Closing Price of the Issuer's common stock on June 18, 2024, the date of the grant. The stock options were issued to the Reporting Person on June 18, 2024, pursuant to a grant under the Issuer's 2022 Omnibus Incentive Plan, as amended and restated (the "Plan"), and in accordance with the terms of a consulting agreement dated June 18, 2024, by and between the Reporting Person and MIRA Pharmaceuticals, Inc. The stock options will vest in three equal tranches, with the first tranche vesting immediately on the grant date of June 18, 2024, the second tranche vesting on December 18, 2024, and the final tranche vesting on June 18, 2025. Represents (i) 25,000 stock options that were issued to the Reporting person on March 25, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $1.16 each and (ii) 16,666 stock options that were issued to the Reporting Person on June 18, 2024, that were vested in full and became exercisable on the same date, pursuant to a grant under the Plan at an exercise price of $0.71 each. /s/ Denil Shekhat 2024-06-21